Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma

Oncology Reports

Volumn 24, Issue 2, 2010, Pages 423-431

  Kohno, Hidekazu ^a   Amatya, Vishwa Jeet ^a   Takeshima, Yukio ^a   Kushitani, Kei ^a   Hattori, Noboru ^a   Kohno, Nobuoki ^a   Inai, Kouki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Demethylation; Mesothelioma; Methylation; SFRP; WIF 1

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA CATENIN; PROTEIN WIF I; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 4; UNCLASSIFIED DRUG; WNT PROTEIN; MEMBRANE PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; SFRP1 PROTEIN, HUMAN; SFRP2 PROTEIN, HUMAN; SFRP4 PROTEIN, HUMAN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; WIF1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CYTOPLASM; DNA METHYLATION; DOWN REGULATION; EXON; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MESOTHELIOMA; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; UPREGULATION; CASE CONTROL STUDY; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; TUMOR CELL CULTURE; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MESOTHELIOMA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TUMOR CELLS, CULTURED;

EID: 77954356044     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000875     Document Type: Article

References (21)

1. Robinson BW and Lake RA: Advances in malignant mesothelioma. N Engl J Med 353: 1591-1603, 2005.
2. Robinson B, Musk A and Lake R: Malignant mesothelioma. Lancet 366: 397-408, 2005.
3. Papp T, Schipper H, Pemsel H, et al: Mutational analysis of Nras, p53, p16INK4a, p14ARF and cdk4 genes in primary human malignant mesotheliomas. Int J Oncol 18: 425-433, 2001.
4. Carbone M, Kratzke R and Testa J: The pathogenesis of mesothelioma. Semin Oncol 29: 2-17, 2002.
5. Murthy S and Testa J: Asbestos, chromosomal deletions and tumor suppressor gene alterations in human malignant mesothelioma. J Cell Physiol 180: 150-157, 1999.
6. Bird A and Wolffe A: Methylation-induced repression - belts, braces and chromatin. Cell 99: 451-454, 1999.
7. Merlo A, Herman J, Mao L, et al: 5′ cpg island methylation is associated with transcriptional silencing of the tumour suppressor p16/cdkn2/MTS1 in human cancers. Nat Med 1: 686-692, 1995.
8. Destro A, Ceresoli G, Baryshnikova E, et al: Gene methylation in pleural mesothelioma: correlations with clinicopathological features and patient's follow-up. Lung Cancer 59: 369-376, 2008.
9. Tomii K, Tsukuda K, Toyooka S, et al: Aberrant promoter methylation of insulin-like growth factor binding protein-3 gene in human cancers. Int J Cancer 120: 566-573, 2007.
10. Tsou J, Galler J, Wali A, et al: DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung Cancer 58: 220-230, 2007.
11. Kimura K, Toyooka S, Tsukuda K, et al: The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas. Oncol Rep 20: 1265-1268, 2008.
12. Wissmann C, Wild P, Kaiser S, et al: WIF1, a component of the wnt pathway, is down-regulated in prostate, breast, lung and bladder cancer. J Pathol 201: 204-212, 2003.
13. Mazieres J, He B, You L, et al: Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 64: 4717-4720, 2004. (Pubitemid 38924512)
14. Taniguchi H, Yamamoto H, Hirata T, et al: Frequent epigenetic inactivation of wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 24: 7946-7952, 2005.
15. Nosho K, Yamamoto H, Takahashi T, et al: Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in PT1 (early invasive) colorectal cancers. Carcinogenesis 28: 1364-1370, 2007.
16. Batra S, Shi Y, Kuchenbecker K, et al: Wnt inhibitory factor-1, a wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma. Biochem Biophys Res Commun 342: 1228-1232, 2006.
17. Travis WD, Brambilla E, Müller-Hermelink HK and Harris CC (eds): Pathology and Genetics. Tumours of the lung, pleura, thymus and heart. World Health Organization Classification of Tumours. IARC Press, Lyon, 2004.
18. Uematsu K, He B, You L, Xu Z, McCormick F and Jablons D: Activation of the wnt pathway in non-small cell lung cancer: evidence of dishevelled overexpression. Oncogene 22: 7218-7221, 2003.
19. Uematsu K, Kanazawa S, You L, et al: Wnt pathway activation in mesothelioma: evidence of dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 63: 4547-4551, 2003. (Pubitemid 36951028)
20. Pu R, Sheng Z, Michael C, Rhode M, Clark D and O'Leary T: Methylation profiling of mesothelioma using real-time methylation-specific PCR: a pilot study. Diagn Cytopathol 35: 498-502, 2007.
21. Urakami S, Shiina H, Enokida H, et al: Epigenetic inactivation of wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical wnt/beta-catenin signaling pathway. Clin Cancer Res 12: 383-391, 2006.